Examples include insulin and glucagon
For instance, in March 2024, according to the Office for Health Improvement and Disparities, a UK-based government department, between March 2022 and March 2023, the percentage of individuals with type 1 diabetes receiving all eight recommended care processes increased by 22%, and for type 2 diabetes, it increased by 21%, while the percentage achieving target HbA1c levels rose to 37.9%
But the game-changer was pivoting resources to tirzepatide and next-gen incretin therapies
Invitrogen, Carlsbad, CA, USA) was measured using the glucose oxidase method
This was the first clinical trial showing that 10 days of administration of alpha lipoic acid is able to manage insulin-stimulated glucose disposal in non-insulin-dependent diabetes mellitus